21 CFR 111.113
§ 111.113 What quality control operations are required for a material review and disposition decision?
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 111.113, § 111.113 What quality control operations are required for a material review and disposition decision?, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/84160
- Permanent ID
ys:prov:84160@1- SHA-256
6639b825d79909c4993b8b40b1dbba2f1fe7471bfe119b549d55f67897bca4ca
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Quality control personnel must conduct a material review and make a disposition decision if:
(1) A specification established in accordance with § 111.70 is not met;
(2) A batch deviates from the master manufacturing record, including when any step established in the master manufacturing record is not completed and including any deviation from specifications;
(3) There is any unanticipated occurrence during the manufacturing operations that adulterates or may lead to adulteration of the component, dietary supplement, or packaging, or could lead to the use of a label not specified in the master manufacturing record;
(4) Calibration of an instrument or control suggests a problem that may have resulted in a failure to ensure the quality of a batch or batches of a dietary supplement; or
(5) A dietary supplement is returned.
(b)(1) When there is a deviation or unanticipated occurrence during the production and in-process control system that results in or could lead to adulteration of a component, dietary supplement, or packaging, or could lead to the use of a label not specified in the master manufacturing record, quality control personnel must reject the component, dietary supplement, packaging, or label unless it approves a treatment, an in-process adjustment, or reprocessing to correct the applicable deviation or occurrence.
(2) When a specification established in accordance with § 111.70 is not met, quality control personnel must reject the component, dietary supplement, package or label, unless quality control personnel approve a treatment, an in-process adjustment, or reprocessing, as permitted in § 111.77.
(c) The person who conducts a material review and makes the disposition decision must, at the time of performance, document that material review and disposition decision.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.